FG
NVO

Foresight Group’s Novo Nordisk NVO Stock Holding History

Foresight Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.28M Buy
+109,935
New +$4.72M 0.95% 37
2026
Q1 		– Sell
-123,759
Closed -$40.3M – 62
2025
Q4 		$40.3M Sell
123,759
-1,246
-1% -$63.7K 6.06% 1
2025
Q3 		$6.94M Buy
125,005
+86
+0.1% +$5.03K 1.04% 33
2025
Q2 		$8.64M Buy
+124,919
New +$8.5M 1.23% 34

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
AIIMS
Analyst IMS Investment Management Services Tel-Aviv, Israel $4.3B AUM 37.33% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Foresight Group's NVO Position: Q2 2026 in Review

Foresight Group opened a new position in Novo Nordisk (NVO) in Q2 2026: 109,935 shares worth $5.28M. The stake represents 0.95% of the portfolio and ranks #37 among its holdings. This is a return to the name: Foresight Group previously reported a position in NVO as recently as Q4 2025.

Foresight Group first reported a position in NVO in Q2 2025 and has held it in 4 quarters since. The position peaked at $40.3M in Q4 2025. 580 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Foresight Group held 109,935 shares of Novo Nordisk worth $5.28M as of Q2 2026.
  • Novo Nordisk was a new Foresight Group position in Q2 2026.
  • Novo Nordisk made up 0.95% of Foresight Group's portfolio in Q2 2026, its #37 holding.
  • Foresight Group first reported a position in Novo Nordisk in Q2 2025 and has held it in 4 quarters since.
  • Foresight Group's Novo Nordisk position peaked at $40.3M in Q4 2025.
  • 580 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Foresight Group's 13F filing for Q2 2026, filed 27 Jul 2026.